Interview Outtake 6: Decreasing the medical burden – Cern Corporation

Bio

Skip to content

Home
Technology
Investors
About Us
News

Home
Technology
Investors
About Us
News

Interview Outtake 6: Decreasing the medical burden

Previous Post Interview Outtake 7: Making the world better

Next Post Interview Outtake 5: Prevalence & Symptoms

Shining Light on Women's Health™

Cern is currently in IRB-approved clinical evaluation.

Quick Links

Home
Technology
Investors
About
News & Updates

Contact

info@cerndevice.com
Orange County, CA
Contact Us →

Clinical

ClinicalTrials.gov →
NCT06933420

Disclaimer: The Cern Device™ is in clinical development and not FDA-cleared or approved at this time. Information on this website is provided for educational purposes only and should not be interpreted as evidence of clinical efficacy.

© 2026 Cern Corporation LLC. All rights reserved.

Terms & Services
Privacy Policy
Cookies